Azerbaijan vs Malta: HIV-positive TB patients on ART (antiretroviral therapy)
Azerbaijan
100.0%
in 2024
Malta
100.0%
in 2023
Azerbaijan rank
1st
Malta rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Azerbaijan
- Malta
How they compare
Azerbaijan currently reports 100.0% against 100.0% in Malta, a difference of 0.0%.
Across all 5 years both countries report, Malta has been ahead every year.
Azerbaijan ranks 1st and Malta ranks 1st of 144 countries.
Malta has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 79.0% | 100.0% | 21.0% | Malta |
| 2020s | 97.0% | 100.0% | 3.0% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Azerbaijan or Malta?
- Azerbaijan, at 100.0% against 100.0% in Malta as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Azerbaijan and Malta?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Malta?
- 5 years are reported by both, from 2015 to 2023.
- How do Azerbaijan and Malta rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Azerbaijan ranks 1st and Malta ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.